The African Union has discontinued plans to secure the Covid-19 vaccine from the Serum Institute of India for African countries and is exploring options with Johnson & Johnson, the director of the Africa Centers for Disease Control and Prevention said Thursday. It was.
John Nkengasong told reporters that the institute will continue to supply AstraZeneca vaccine to Africa through the Covacs vaccine sharing facility, but the African Union will seek additional supplies from Johnson & Johnson.
The statement was released the day after European and British health regulators said they had found a possible link between the AstraZeneca vaccine and reports of a very rare stroke, but people. Reaffirmed its importance in protecting.
Nukengason said the possible relevance had nothing to do with the African Union’s decision. Block of 55 member states has moved to the Johnson & Johnson vaccine, he said, citing a deal signed last week to secure up to 400 million doses from the third quarter of this year.
“… I was able to compliment each other, not the overlapping efforts, just by clearly understanding how to avoid overlapping efforts with the Serum Institute,” he said.
AU discontinues plans to buy Covid vaccine from SSI in India
Source link AU discontinues plans to buy Covid vaccine from SSI in India